Bimekizumab versus secukinumab continuous maintenance of response at every visit through one year in patients with moderate to severe plaque psoriasis: Post-hoc results from the BE RADIANT phase 3b trial

N/A

Saved in:

Bibliographic Details
Published in	Skin (Milwood, N.Y.) Vol. 6; no. 6; p. s70
Main Authors	Warren, RB, Conrad, C, Foley, P, Iversen, L, Langley, RG, Kokolakis, G, Davis, L, Vanvoorden, V, Wiegratz, S, Merola, JF
Format	Journal Article
Language	English
Published	16.11.2022
Online Access	Get full text

Loading…